Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,989 | 99,068 | 57,206 | 4,601 | 77,126 |
| Marketable Securities | 239,338 | 159,984 | 186,796 | 252,223 | 298,821 |
| Receivables | 47,464 | 56,399 | 60,831 | 52,194 | 20,132 |
| TOTAL | $341,869 | $326,957 | $319,021 | $321,155 | $428,219 |
| Non-Current Assets | |||||
| PPE Net | 4,815 | 5,435 | 5,943 | 6,613 | 7,038 |
| Investments And Advances | 42,218 | 88,668 | 108,416 | 115,706 | 24,493 |
| Other Non-Current Assets | 17,916 | 19,534 | 5,411 | 6,962 | 8,017 |
| TOTAL | $64,949 | $113,637 | $119,770 | $129,281 | $39,548 |
| Total Assets | $406,818 | $440,594 | $438,791 | $450,436 | $467,767 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,985 | 7,841 | 9,540 | 5,895 | 5,699 |
| Accrued Expenses | 21,740 | 26,580 | 22,429 | 17,695 | 15,744 |
| TOTAL | $30,738 | $37,890 | $36,172 | $28,624 | $26,618 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17,497 | 18,320 | 3,190 | 3,962 | 5,117 |
| TOTAL | $17,497 | $18,320 | $3,190 | $3,962 | $5,117 |
| Total Liabilities | $48,235 | $56,210 | $39,362 | $32,586 | $31,735 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,713 | 20,530 | 20,325 | 20,215 | 20,195 |
| Common Shares | 206 | 205 | 202 | 202 | 202 |
| Retained earnings | -15,131 | 18,461 | 48,576 | 73,175 | 97,199 |
| Other shareholders' equity | -3,037 | -1,006 | -382 | -264 | 55 |
| TOTAL | $358,583 | $384,384 | $399,429 | $417,850 | $436,032 |
| Total Liabilities And Equity | $406,818 | $440,594 | $438,791 | $450,436 | $467,767 |